ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Renal Graft Survival among Primary, Re-Transplant, and Kidney after Solid Organ Transplantation: A Single Center Experience

R. Nusrat, P. Sood, A. Tevar, R. Shapiro, A. Humar, S. Hariharan

University of Pittsburgh, Pittsburgh

Meeting: 2013 American Transplant Congress

Abstract number: 457

Introduction: With improved patient outcomes after renal transplants, repeat renal and kidney after solid organs are increasingly being done. Because of paucity of outcomes data in these groups when compared to primary transplants, we conducted this retrospective analysis to study their differential outcomes.

Methodology: Registry data for kidney transplantations at UPMC from Jan 2000- Dec 2011 was used. We compared death censored renal graft survival among the three groups using Cox regression analyses, adjusting for recipient/donor age, sex, ethnicity, donor type (living/DBD/DCD), CIT, DGF and rejection at 6 and 12 months.

Results: The details of subjects in each group are summarized in table 1. Median follow up time was 54 months. The 1, 3 and 5 year graft survival rates were 93.8%, 85.7%, 79.4% among primary, 89.8%, 80.8%, 76.2% among re-transplant and 93.2%, 86.9%, 80.7% among other solid organ transplant recipients, respectively. We observed no significant difference in unadjusted actuarial (p=0.24) or death-censored graft survival (p=0.418) between the 3 groups. This finding was confirmed on multivariate analysis adjusting for significant co-variants.

Conclusion: In our single center study, we found that the renal transplant graft survival after primary, repeat and renal transplant after other solid organ transplants were similar.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Nusrat R, Sood P, Tevar A, Shapiro R, Humar A, Hariharan S. Renal Graft Survival among Primary, Re-Transplant, and Kidney after Solid Organ Transplantation: A Single Center Experience [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/renal-graft-survival-among-primary-re-transplant-and-kidney-after-solid-organ-transplantation-a-single-center-experience/. Accessed May 17, 2025.

« Back to 2013 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences

  Primary (N=1504) Repeat (N=334) Post Solid Organ (N=176)
Recipient      
Age at Transplant (Mean, Yrs)* 52.4 42.9 55.7
Sex (M:F) 904 (60.1%): 600(39.9%) 207(62.0%):127(38.0%) 118(67.0%):58(33.0%)
Race (N,%)*      
White 1229, 81.7% 291,87.1% 161,91.5%
AA 233, 15.5% 31,9.3% 9,5.1%
Other 42, 2.8% 12, 3.6% 6,3.4%
Donor      
Age (Mean,Yrs)* 40.84 35.68 38.8
Sex (M:F)* 704(52.9%):796(46.8%) 192(57.5%):140(41.9%) 92(52.3%):84(47.7%)
Ethnicity (N,%)*      
White 1291,85.5% 296,88.6% 157,89.2%
Black 163, 10.8% 296,88.6% 157,89.2%
Other 50, 3.3% 15, 4.5% 9,5.1%
Transplant      
Induction Agent (N, %)*      
Campath 1168, 77.7% 235,70.4% 113, 64.2%
Thymoglobulin 165, 11.0% 48, 14.4% 4,2.3%
Other 171,11.4% 51,15.3% 55,33.5%
CIT (Mean Min) 963.8 1027.61 1000.15
DGF(Y:N) 229(15.2%):1274(84.7%) 61(18.3%): 272(81.4%) 24(13.6%):152(86.4%)
Donor type (N,%)*      
Living 584, 38.8% 102,30.5% 59,33.7%
DBD 799, 53.1% 203, 60.7% 8,4.5%
DCD 120, 7.9% 28, 8.3% 8,4.5%
ACR 6 mos(Y:N) 231(15.3%):1273(84.6%) 68(20.3%):266(79.6%) 26(15%):150(35%)